Cannara Biotech

(TSXV) LOVE

Current PriceN/A

Market CapN/A

Since IPO (2019)-44%

5 Year+23%

1 Year+35%

1 Month-10%

Cannara Biotech Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$113.26M

Net Income (TTM)

$10.16M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

LOVE News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cannara Biotech

Industry

Personal Products

Sector

Consumer Staples

Employees

452

CEO

Zohar Krivorot

Website

www.cannara.ca

Headquarters

Saint-Laurent, QC H4N 3M9, CA

LOVE Financials

Key Financial Metrics (TTM)

Gross Margin

39%

Operating Margin

14%

Net Income Margin

10%

Return on Equity

12%

Return on Capital

11%

Return on Assets

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$47.22M

Operating Income

$22.20M

EBITDA

$28.18M

Operating Cash Flow

$20.01M

Capital Expenditure

$6.36M

Free Cash Flow

$13.65M

Cash & ST Invst.

$14.36M

Total Debt

$41.58M

Cannara Biotech Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

$27.18M

+2.2%

Gross Profit

$11.65M

-2.6%

Gross Margin

42.86%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

461

N/A

Net Income

$1.66M

-49.8%

EBITDA

$4.63M

-36.9%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Net Cash

$12.32M

+71.9%

Accounts Receivable

$12.47M

-19.9%

Inventory

$54.15M

+19.2%

Long Term Debt

$25.22M

-26.0%

Short Term Debt

$9.00M

-39.1%

Return on Assets

6.79%

N/A

Return on Invested Capital

11.14%

N/A

Free Cash Flow

$286.30K

+94.1%

Operating Cash Flow

$2.95M

+187.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

HLS.TOHLS Therapeutics Inc.

HLS.TOHLS Therapeutics Inc.$4.67+0.00%

RX.VBioSyent Inc.

RX.VBioSyent Inc.$14.50+0.49%

CRDL.TOCardiol Therapeutics Inc.

CRDL.TOCardiol Therapeutics Inc.$1.79-4.28%

XLY.TOAuxly Cannabis Group Inc.

XLY.TOAuxly Cannabis Group Inc.$0.14-3.33%

DB.VDecibel Cannabis Company Inc.

DB.VDecibel Cannabis Company Inc.$0.12-4.17%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.40-0.08%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$76.27-0.03%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.49+0.03%

SLESuper League Enterprise

SLESuper League Enterprise$6.04+0.48%

PIIIP3 Health Partners

PIIIP3 Health Partners$11.36+1.82%

CONLGraniteShares ETF Trust - GraniteShares 2x Long Coin Daily ETF

CONLGraniteShares ETF Trust - GraniteShares 2x Long Coin Daily ETF$7.98-0.17%

BMNRBitmine Immersion Technologies

BMNRBitmine Immersion Technologies$20.35-0.07%

Questions About LOVE

What is the current price of Cannara Biotech?

Cannara Biotech is trading at N/A per share.

What is the 52-week range for Cannara Biotech?

Over the past 52 weeks, Cannara Biotech has traded between N/A and N/A.

How much debt does Cannara Biotech have?

As of the most recent reporting period, Cannara Biotech reported total debt of $34.22M.

How much cash does Cannara Biotech have on hand?

Cannara Biotech reported $21.90M in cash and cash equivalents in its most recent financial results.

What is Cannara Biotech’s dividend yield?

Cannara Biotech does not currently have a dividend yield.

Cannara Biotech

Cannara Biotech Financials at a Glance

LOVE News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Cannara Biotech

LOVE Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Cannara Biotech Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About LOVE

What is the current price of Cannara Biotech?

What is the 52-week range for Cannara Biotech?

How much debt does Cannara Biotech have?

How much cash does Cannara Biotech have on hand?

What is Cannara Biotech’s dividend yield?

Premium Investing Services